Skip to main content
BrainCited

Melatonin के लिए Sleep-Related Cognitive Impairment

C

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dsleep\u002Dcognitive'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

निष्कर्ष

Well-established for sleep optimization, melatonin may support cognitive function indirectly by promoting glymphatic clearance of beta-amyloid and other metabolic waste during sleep.

Key Study Findings

review
Pediatric Insomnia.
Dose: Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) बनाम: Placebo प्रभाव: CBT-I most effective treatment; melatonin beneficial in children with ASD or ADHD; limited evidence None
Other
Banxia Shumi Decoction Improves Sleep and Neural Function in Insomnia Male Rats via BDNF/TrkB/CREB-Dependent Melatonin …
Dose: None बनाम: PCPA-induced insomnia model control Outcome: Sleep quality and cognitive function in rat model प्रभाव: None None

जनसंख्या: PCPA-induced insomnia male rats

Randomized Controlled Trial n=322 5 weeks Double-blind
Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, …
Dose: 20 mg or 50 mg tasimelteon daily बनाम: Placebo Outcome: Latency to persistent sleep (PSG) प्रभाव: -44.9 min (20mg) / -46.3 min (50mg) vs -28.2 (placebo) <0.001

जनसंख्या: Patients with primary insomnia (sleep onset difficulty)

Review
Irregular sleep-wake rhythm disorder: From the pathophysiologic perspective to the treatment.
Dose: None बनाम: None Outcome: ISWRD symptom management प्रभाव: None None

जनसंख्या: Patients with irregular sleep-wake rhythm disorder

review
Insomnia in older adults: A review of treatment options.
Dose: various बनाम: Placebo प्रभाव: None None
Review
Commonly encountered symptoms and their management in patients with cirrhosis.
Dose: None बनाम: None Outcome: Pain outcomes प्रभाव: None None

जनसंख्या: Insomnia patients

Key Statistics

15

अध्ययन

2000

प्रतिभागी

Positive

C

ग्रेड

Referenced Papers

Pediatrics in review 2026
Cleveland Clinic journal … 2025 12 उद्धरण
Current opinion in … 2024 12 उद्धरण
Frontiers in medicine 2024 4 उद्धरण
La Revue du … 2024
Journal of sleep … 2023 12 उद्धरण
Frontiers in neuroscience 2023 5 उद्धरण
Current drug safety 2023 2 उद्धरण
Progress in neuro-psychopharmacology … 2021 68 उद्धरण
Climacteric : the … 2020 97 उद्धरण
Neurotherapeutics : the … 2020 80 उद्धरण
Current treatment options … 2020 29 उद्धरण
Human brain mapping 2020 15 उद्धरण
Dermatitis : contact, … 2019 7 उद्धरण
Journal of sleep … 2017 1691 उद्धरण
Neurological research 2017 331 उद्धरण
Nutrients 2017 301 उद्धरण
Current treatment options … 2017 56 उद्धरण
Clinical therapeutics 2016 328 उद्धरण
Chest 2016 109 उद्धरण
European heart journal. … 2016 77 उद्धरण
Diabetes, obesity & … 2015 132 उद्धरण
Alcohol (Fayetteville, N.Y.) 2015 122 उद्धरण
Menopause (New York, … 2015 73 उद्धरण
Chest 2013 53 उद्धरण
Pharmacological reports : … 2011 99 उद्धरण
Der Nervenarzt 2009 6 उद्धरण
Pharmacotherapy 2007 117 उद्धरण
Tidsskrift for den … 2006
Brain research. Molecular … 2005 160 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
0.5-5 mg/day
sleepcognitivesupport:
0.5-3 mg 30-60 min before bed

अधिकतम सीमा: 10 mg/day (higher doses not more effective)

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) -- Positive --
None -- Positive --
20 mg or 50 mg tasimelteon daily 5 weeks Positive 322
None -- Mixed --
various -- Positive --
None -- Neutral --
None -- Positive 6528
Z-drugs, melatonin, orexin antagonists -- Positive --

सेवन का सर्वोत्तम समय: 30-60 minutes before bedtime

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams

ज्ञात अंतःक्रियाएँ

  • Sedative medications (additive drowsiness)
  • Blood thinners (may increase bleeding risk)
  • Diabetes medications (may affect blood sugar)
  • Immunosuppressants (may stimulate immune function)
  • Oral contraceptives (may increase melatonin levels)

सहनीय अधिकतम सेवन: 10 mg/day (higher doses not more effective)

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Melatonin help with Sleep-Related Cognitive Impairment?
Based on 15 studies with 2,000 participants, there is limited but promising evidence that Melatonin may support Sleep-Related Cognitive Impairment management. Our evidence grade is C (Some Evidence).
How much Melatonin should I take for Sleep-Related Cognitive Impairment?
Studies have used various dosages. A commonly studied range is 0.5-5 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Melatonin?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Melatonin and Sleep-Related Cognitive Impairment?
We rate the evidence as Grade C (Some Evidence). This rating is based on 15 peer-reviewed studies with 2,000 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Sleep-Related Cognitive Impairment

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।